← Back to Search

Behavioral Intervention

Happy Bob App for Type 1 Diabetes

N/A
Recruiting
Research Sponsored by Children's Mercy Hospital Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Type 1 Diabetes, Use Dexcom and Smart Phone
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0,3,6 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if using the Happy Bob phone app with peer support can help young people with Type 1 Diabetes. They want to know if the app is easy to use and helpful, and

Who is the study for?
This trial is for young people with Type 1 Diabetes who use a Dexcom device and a smartphone. It's designed to see if the Happy Bob app helps them manage their diabetes by providing peer support and monitoring.
What is being tested?
The study tests the Happy Bob app, focusing on its user-friendliness, how well it's liked, and its effectiveness in improving treatment adherence and social support over six months, including some remote patient monitoring sessions.
What are the potential side effects?
Since this trial involves using an app rather than medication or medical procedures, traditional side effects are not expected. However, participants may experience increased screen time.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0,3,6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0,3,6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Diabetes Treatment Satisfaction Questionnaire
Happy Bob App User Metrics
Health Information Technology Usability Evaluation Scale (Health-ITUES)
+3 more
Secondary study objectives
Diabetes Treatment Outcomes
Self Efficacy for Diabetes (SED) Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: RPM (remote patient monitoring)Experimental Treatment2 Interventions
Group II: Non-RPMActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
RPM
2018
N/A
~50

Find a Location

Who is running the clinical trial?

Children's Mercy Hospital Kansas CityLead Sponsor
256 Previous Clinical Trials
940,255 Total Patients Enrolled
~40 spots leftby Mar 2025